ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[FGF5, MELK, WEE1]
GO:0045606;positive regulation of epidermal cell differentiation;7.0;0.8653626801206646;0.7836007053175329;9.517298617381897;258.7690385433134;6.641579411751319;0.008660766843029667;0.6905700452391912;[SFN]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[LHCGR, NASP]
GO:0022408;negative regulation of cell-cell adhesion;6.0;0.5806842727486619;0.6134624489644754;7.765305819281922;52.92767189200162;4.7081694254602375;0.0017714415464131104;0.5638963159604501;[IFNA2, TNR]
GO:0033141;positive regulation of peptidyl-serine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;940.2079225453168;6.781341354126479;0.03146791303539702;0.7792270645443136;[IFNA5, IFNA4, IFNA7, IFNA14, IFNA16, IFNA2, IFNA8, IFNA21, IFNA10]
GO:0023019;signal transduction involved in regulation of gene expression;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;6.781341354126479;7.75488093814194E-4;0.6370391240755715;[FGF5]
GO:0036092;phosphatidylinositol-3-phosphate biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;663.4179201744114;5.8650506222523235;0.02220400075087234;0.6961795867550195;[FGF5]
GO:0008543;fibroblast growth factor receptor signaling pathway;8.0;0.7090535922965819;0.729526796148291;8.567652291806858;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[FGF5]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[FGF5]
GO:0045762;positive regulation of adenylate cyclase activity;12.0;0.8933024483968273;0.8947715367885583;9.589303539338841;6276.064729494611;7.697632086000634;0.21005423840463325;0.8417775754447168;[LHCGR]
GO:0002286;T cell activation involved in immune response;6.0;0.6997970393407541;0.6730188322605215;8.890925309361343;82.05045983278045;5.845247994956144;0.002746155049983451;0.6220465668840318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, IFNA21, IFNA14, IFNA16, IFNA10]
GO:0008306;associative learning;7.0;0.8436909121759173;0.7727648213451592;9.223059144383958;22.449675191779697;5.459585514144159;7.513704252729093E-4;0.6301228223472235;[TNR, MEIS2]
GO:0042699;follicle-stimulating hormone signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;62.84085921303097;8.16763571524637;0.002103227004758593;0.7408135829017477;[LHCGR]
GO:0009755;hormone-mediated signaling pathway;5.0;0.6519675769143192;0.6162248003180799;7.98629651723503;23.17027026302992;4.61801832846594;7.75488093814194E-4;0.5264066839384828;[NR3C2, LHCGR]
GO:0003334;keratinocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.35043118565193;7.57984905034425;0.0011496780184027697;0.6778748447945537;[SFN]
GO:0071373;cellular response to luteinizing hormone stimulus;8.0;1.0;0.875;9.628524252492122;601.1788189541068;8.67846133901236;0.020120914044583264;0.8188169164668168;[LHCGR]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[SFN]
GO:0001545;primary ovarian follicle growth;3.0;0.8933024483968273;0.6447715367885581;9.292052015870908;21.717098748465986;8.67846133901236;7.268517509911946E-4;0.6419372290569613;[LHCGR]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[ITGB4]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[SFN]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFNA14, IFNA16, IFNA10, IFNA21, IFNA5, IFNA4, IFNA7, IFNA2, IFNA8]
GO:0010811;positive regulation of cell-substrate adhesion;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;35.30989762708448;5.049685808968129;0.0011817904967337807;0.5484821789659555;[COL8A1]
GO:0060291;long-term synaptic potentiation;8.0;1.0;0.875;9.628524252492122;145.7697243391103;5.948432231191374;0.004878781489395318;0.6792031009335148;[TNR]
GO:0051968;positive regulation of synaptic transmission, glutamatergic;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;135.83014596643335;6.375876246018314;0.004546112746301595;0.701062607729944;[TNR]
GO:0032962;positive regulation of inositol trisphosphate biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;985.0638483814348;8.16763571524637;0.03296920050541953;0.8139338954918922;[LHCGR]
GO:0060672;epithelial cell morphogenesis involved in placental branching;7.0;1.0;0.8509193652572005;9.628524252492122;83.24866829651714;8.67846133901236;0.002786258008947111;0.7947362817240173;[ST14]
GO:0046827;positive regulation of protein export from nucleus;9.0;0.811012628672052;0.801746939516315;9.431813958246067;516.7269860224134;6.7325511899570465;0.017294387198074676;0.740543606130341;[SFN]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, IFNA14, IFNA16, IFNA10, IFNA21]
GO:0050805;negative regulation of synaptic transmission;7.0;0.6835726970475526;0.6927057137809769;8.781226392104918;101.84774727695553;5.6339389012889365;0.00340875244433803;0.6390392626740691;[TNR]
GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;990.0589542238915;6.599019797332524;0.033136382202663156;0.7527151911823093;[SFN]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IFNA4, IFNA7, IFNA14, IFNA16, IFNA2, IFNA8, IFNA21, IFNA10]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[SFN]
GO:0007189;adenylate cyclase-activating G-protein coupled receptor signaling pathway;9.0;0.7763722522362496;0.7844267512984139;9.249034630787218;56.871035456649615;5.192106149009898;0.0019034223761250782;0.6617651750982834;[LHCGR]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[SFN, EZH2, ARHGAP6, MMP12, ADAMTS20, FGF5, SKP2, IFNA2, PRL, MAP4K1]
GO:0097186;amelogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;26.73958370240551;7.474488534686424;8.949498024565515E-4;0.7053660038532718;[ITGB4]
GO:0042700;luteinizing hormone signaling pathway;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;26.976932752798508;8.67846133901236;9.028936615729279E-4;0.7669372290569613;[LHCGR]
GO:0002323;natural killer cell activation involved in immune response;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;81.35731265221925;6.641579411751319;0.0027229560376420305;0.6627709925721352;[IFNA5, IFNA4, IFNA7, IFNA14, IFNA16, IFNA2, IFNA8, IFNA21, IFNA10]
GO:0098586;cellular response to virus;6.0;0.7763722522362496;0.7113064387082693;8.999915593069748;28.654098265158677;6.375876246018314;9.59026881920657E-4;0.6491829203200885;[MMP12]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[ST14]
GO:0048692;negative regulation of axon extension involved in regeneration;13.0;1.0;0.9625549647676366;9.628524252492122;2958.2044458963533;9.777073627680469;0.09900844059299502;0.9625549647676366;[TNR]
GO:0051971;positive regulation of transmission of nerve impulse;7.0;0.9326813400603323;0.8172600352873667;9.567899630675686;161.98963704071667;7.9853141584524145;0.005421647370544368;0.7592887026755414;[TNR]
GO:0030539;male genitalia development;5.0;1.0;0.7902410118609202;9.628524252492122;66.31594138202881;6.832634648514029;0.002219534877584045;0.639662265535933;[LHCGR]
GO:0048333;mesodermal cell differentiation;4.0;0.8259837884571596;0.6629918942285797;8.935377071932177;21.066225782797595;7.138016298065211;7.050676185779127E-4;0.6150384854347593;[ITGB4]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[MMP12, RANBP1]
GO:0035987;endodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;6.444869117505266;7.050676185779127E-4;0.5795909063862833;[COL8A1]
GO:0001836;release of cytochrome c from mitochondria;6.0;1.0;0.8231203125901445;9.628524252492122;22.134985108306864;6.686031174322154;7.408380313817617E-4;0.665044257777226;[SFN]
GO:0070831;basement membrane assembly;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;38.848171793302654;8.67846133901236;0.0013002133488370917;0.7669372290569613;[LAMC2]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[FGF5, IFNA14, IFNA16, IFNA10, IFNA21, IFNA5, IFNA4, IFNA7, IFNA2, PRL, IFNA8]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[FGF5]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[LAMC2]
GO:0031581;hemidesmosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;36.796901128588246;7.292166977892469;0.0012315591657128446;0.6960420709600095;[ITGB4, LAMC2]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CDC6, MMP12, FGF5, SKP2, PRL, LAMC2, MEIS2]
GO:0060340;positive regulation of type I interferon-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;527.9279232538245;7.379178354882098;0.017669272487020958;0.7523715242355574;[MMP12]
GO:0022029;telencephalon cell migration;6.0;0.6873818243518346;0.6668112247660618;8.68406264365127;21.32120993996455;6.250713103064308;7.136017088474478E-4;0.6427820713687392;[TNR]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[MMP12, ATAD2, E2F7, PRL, ARID4A, HMGA1, MEIS2]
GO:0061436;establishment of skin barrier;8.0;1.0;0.875;9.628524252492122;44.874432655588755;6.781341354126479;0.0015019068766151408;0.7217981122146513;[STMN1, SFN]
GO:0000079;regulation of cyclin-dependent protein serine/threonine kinase activity;11.0;0.7866048967936545;0.8257314007264895;9.474373572664863;340.6851601099881;5.181953777545879;0.011402425712143147;0.6974343094988531;[PKMYT1, SFN, CDC6]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[EZH2, MMP12, TLE4, RFC1, E2F7, MEIS2]
GO:0010839;negative regulation of keratinocyte proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;86.66714155745981;7.212124270218933;0.002900671232564666;0.7197477358342742;[SFN]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[FGF5, MAP4K1]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[ITGB4]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[PCNA, SFN, E2F7]
GO:0051781;positive regulation of cell division;5.0;0.6763753087927167;0.6284286662572787;8.438940185618286;42.28939918509474;5.358233019883872;0.0014153881327367882;0.5642612976810992;[FGF5, CDC6, CIT]
GO:0043330;response to exogenous dsRNA;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;30.956451235720028;5.970411137910149;0.0010360845638621964;0.6284474158353811;[IFNA5, IFNA4, IFNA7, IFNA14, IFNA16, IFNA2, IFNA8, IFNA21, IFNA10]
GO:0045670;regulation of osteoclast differentiation;8.0;0.8259837884571596;0.7879918942285797;9.485423408851448;139.67875005531917;5.587418885654044;0.0046749220616377945;0.6607408616538982;[LHCGR]
GO:0050691;regulation of defense response to virus by host;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;72.38922322033065;6.166155715036245;0.0024228021551132095;0.6662568552797195;[MMP12]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[MMP12]
GO:0060054;positive regulation of epithelial cell proliferation involved in wound healing;7.0;1.0;0.8509193652572005;9.628524252492122;67.70654393410987;7.697632086000634;0.0022660770935411527;0.7445766281117727;[MMP12]
GO:0060339;negative regulation of type I interferon-mediated signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.593432932680852;528.6118652587121;7.57984905034425;0.017692163410416704;0.7626338329336335;[MMP12]
GO:1902741;positive regulation of interferon-alpha secretion;10.0;1.0;0.9152410118609203;9.628524252492122;774.0580298608876;7.8311634786251565;0.025907025652444588;0.8157270763441555;[MMP12]
GO:0007200;phospholipase C-activating G-protein coupled receptor signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.976932752798508;5.288437257948329;9.028936615729279E-4;0.5935712398991049;[LHCGR]
GO:0045636;positive regulation of melanocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;190.69673191605972;8.390779266560578;0.006382448001314043;0.7800242071602487;[ADAMTS20]
GO:0060337;type I interferon signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.587418885654044;0.00101047745553359;0.6366602269110988;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, IFNA21, IFNA14, IFNA16, IFNA10]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, IFNA14, IFNA16, IFNA10, IFNA21, HIST1H2BK]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SFN, UNG, ADAMTS20]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[ST14, MMP12, ADAMTS20, SKP2, RANBP1]
GO:0071901;negative regulation of protein serine/threonine kinase activity;11.0;0.7369933605727446;0.8009256326160346;9.385578073881732;1262.8536775520981;4.8942717050940985;0.0422665760931464;0.6827222349350845;[SFN]
GO:0010001;glial cell differentiation;4.0;0.7192862368539868;0.6096431184269935;8.404748820870006;21.066225782797595;5.528578385631111;7.050676185779127E-4;0.5327317557463623;[FGF5]
